Robert Kamen

Director, Jounce Therapeutics.

Companies

Jounce TherapeuticsBoard member Jan 26, 2017 to May 4, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Jounce Therapeutics JNCE0 shares²May 3, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 3, 2023U 33,875 shares of Jounce Therapeutics²
May 3, 2023U 60,975 shares of Jounce Therapeutics²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARJounce Therapeutics, Board member
2
SEC EDGARJounce Therapeutics shares after the filing of May 3, 2023